About Us

food allergy desensitization

Intrommune is a New York City-based biotechnology company dedicated to simplifying allergy immunotherapy.

Intrommune’s core technology enables immunotherapeutic agents to be delivered in a specially formulated toothpaste designed to incorporate and stabilize allergenic proteins, representing a new therapeutic approach for the treatment of peanut and other food allergies.

Conducting allergy immunotherapy via teeth brushing is referred to as oral mucosal immunotherapy (OMIT). OMIT delivers allergenic proteins to the areas of the oral cavity, potentially driving the immune system toward tolerance without ingestion of the allergen. OMIT may address a significant health care need in the industrialized world, where the spread of food allergies has been characterized as an “epidemic.”

Intrommune’s mission is to develop safe and effective options for food allergy sufferers so they and their loved ones can live their lives without fear.

Company Leadership

Management

Michael Nelson

Michael Nelson, JD

Chief Executive Officer

Stuart Loesch

Stuart Loesch

President

Alain Van Loo

Alain Van Loo

Chief Operating Officer

Sergi Trill

Prof. Dr. Sergi Trilla

Chief Strategy Officer

Nandini Murthy

Head of Regulatory

Wendy_Perrow

Wendy Perrow, MBA

Head of Innovation

Ray Forsland

Ray Forslund Ph. D, MBA

Head of Chemistry, Manufacturing and Controls

Chris Schuster

Chris Schuster

Chief Financial Officer

Dr Berger

William Berger, MD, MBA

Head of Clinical Development

Scientific Advisory Board

William Reisacher, MD

Inventor of OMIT; Senior Scientific Advisor, Chair

Sharon Chinthrajah, M.D.

Medical Advisor

Lara Gross, M.D.

Medical Advisor

Greg Plunkett, PhD

CMC Advisor

Saul Fink

CMC Advisor

Anthony Robinson, CRNP, MBA

Clinical Advisor

Gerard Kugel DMD, MS, PhD

Dental Advisor

Business Advisory Board

Jotin Marango, MD, PHD

Corporate Development & Investment Advisor, Chair

Tonya Winders, MBA

Stakeholder Outreach Advisor

Terrence Tormey

Business Development Advisor

Jack Levitt, MBA

Executive Development Advisor

Mark Durham

Human Capital Advisor

Moises “Moe” V. Vela, Jr.

Business Development Advisor

Miles McLennan, MBA

Business Development Advisor

News & Resources

Want to learn more about Intrommune and our OMIT technology?
oral allergy desensitization
food immunotherapy
new treatment for food allergies
oit allergy therapy